Medicine Grand Rounds: Gastric Intestinal Metaplasia and Gastric Cancer

When:
August 29, 2018 @ 8:00 am – 9:00 am
2018-08-29T08:00:00-07:00
2018-08-29T09:00:00-07:00
Where:
LKSC Berg Hall
Li Ka Shing Building
291 Campus Drive, Palo Alto, CA 94305
USA
Cost:
Free
Contact:
Talia Ochoa
Medicine Grand Rounds: Gastric Intestinal Metaplasia and Gastric Cancer @ LKSC Berg Hall | Palo Alto | California | United States

Presenter: Joo Ha Hwang, MD, PhD
Professor of Gastroenterology and Hepatology

Stanford University

Dr. Hwang specializes in early detection of gastrointestinal malignancies including esophageal cancer, gastric (stomach) cancer, pancreatic cancer, bile duct cancer and colon cancer. Dr. Hwang performs advanced endoscopic procedures including EUS-FNA, ERCP and enteroscopy. In addition, Dr. Hwang also performs per-oral endoscopic myotomy (POEM), endoscopic mucosal resection (EMR) to resect large colorectal polyps, and endoscopic submucosal dissection (ESD) to resect early esophageal, gastric, and colorectal cancers.

Dr. Hwang received his bachelor’s degree from the University of Illinois at Champaign-Urbana in electrical engineering. He then received his M.D. degree from the University of Chicago and his Ph.D. in bioengineering from the University of Washington. He did his residency in internal medicine and fellowship in gastroenterology at the University of Washington and was a faculty member at the University of Washington from 2004 to 2017. He has been selected as one of “Seattle’s Top Doctors” by both Seattle Magazine and Seattle Metropolitan Magazine.

Dr. Hwang is board certified in gastroenterology. He is active with local, national and international professional societies. He is a fellow of the American Society of Gastrointestinal Endoscopy (FASGE) and is a past-president of the Pacific Northwest Gastroenterology Society.

In addition to his clinical activities, Dr. Hwang actively participates in research related to treatment of pancreatic cancer with focused ultrasound. He currently has NIH funding to investigate the use of focused ultrasound for enhancing drug delivery to pancreatic tumors. He is the current president of the International Society for Therapeutic Ultrasound (ISTU).